1. Home
  2. NUWE vs AEMD Comparison

NUWE vs AEMD Comparison

Compare NUWE & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuwellis Inc.

NUWE

Nuwellis Inc.

HOLD

Current Price

$2.32

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$3.55

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUWE
AEMD
Founded
1999
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
3.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NUWE
AEMD
Price
$2.32
$3.55
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$287.50
AVG Volume (30 Days)
48.2K
84.6K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,167,999.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$3.42
52 Week High
$70.14
$84.40

Technical Indicators

Market Signals
Indicator
NUWE
AEMD
Relative Strength Index (RSI) 42.18 46.34
Support Level $2.24 $3.87
Resistance Level $2.55 $4.96
Average True Range (ATR) 0.19 0.47
MACD 0.04 -0.09
Stochastic Oscillator 46.72 14.14

Price Performance

Historical Comparison
NUWE
AEMD

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: